Table 1

Participant baseline characteristics

CharacteristicHCV-treatedHCV-untreatedHCV-uninfectedp value
HCV-treated v. HCV-untreatedHCV-treated v. HCV-uninfectedHCV-untreated v. HCV-uninfected
Participants89311786217862
Sex
 Male4810 (53.86)9620 (53.86)9620 (53.86)> 0.99> 0.99> 0.99
 Female4121 (46.14)8242 (46.14)8242 (46.14)
Mean age, yr50.22 ± 10.6150.33 ± 11.1149.72 ± 11.72
Age range, yr
 20–391535 (17.19)3070 (17.19)3070 (17.19)> 0.99> 0.99> 0.99
 40–492473 (27.69)4946 (27.69)4946 (27.69)
 50–593242 (36.30)6484 (36.30)6484 (36.30)
 ≥ 601681 (18.82)3362 (18.82)3362 (18.82)
NHI registration location
 Urban2169 (24.29)4338 (24.29)4338 (24.29)> 0.99> 0.99> 0.99
 Township2755 (30.85)5510 (30.85)5510 (30.85)
 Rural4007 (44.87)8014 (44.87)8014 (44.87)
Charlson Comorbidity Index score
 04244 (47.52)8488 (47.52)8488 (47.52)> 0.99> 0.99> 0.99
 12992 (33.50)5984 (33.50)5984 (33.50)
 ≥ 21695 (18.98)3390 (18.98)3390 (18.98)
Index year
 2003–20064348 (48.68)8696 (48.68)8696 (48.68)> 0.99> 0.99> 0.99
 2007–20092775 (31.07)5550 (31.07)5550 (31.07)
 2010–20121808 (20.24)3616 (20.24)3616 (20.24)
Baseline risk factor
 Liver cirrhosis965 (10.81)1071 (6.00)7 (0.04)< 0.001< 0.001< 0.001
 Chronic obstructive pulmonary disease1033 (11.57)2094 (11.72)1733 (9.70)0.70< 0.001< 0.001
 End-stage renal disease60 (0.67)499 (2.79)41 (0.23)< 0.001< 0.001< 0.001
 Diabetes mellitus1673 (18.73)4071 (22.79)3254 (18.22)< 0.0010.30< 0.001
 Hypertension2634 (29.49)6315 (35.35)4970 (27.82)< 0.0010.004< 0.001
 Dyslipidemia1095 (12.26)3640 (20.38)3211 (17.98)< 0.001< 0.001< 0.001
 Cardiovascular events227 (2.54)729 (4.08)480 (2.69)< 0.0010.48< 0.001
 Stroke299 (3.35)944 (5.28)878 (4.92)< 0.001< 0.0010.11
  • HCV = hepatitis C virus.

  • Values are n (%) or mean ± standard deviation.